Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Risks of non-sedating antihistamines.

× No keyword cloud information.

20 in total

1. Ventricular arrhythmias and nonsedating antihistamines.

Authors: S Suissa
Journal: Br J Clin Pharmacol Date: 2000-04 Impact factor: 4.335

2. Risk of torsades de pointes with non-cardiac drugs. Doctors need to be aware that many drugs can cause qt prolongation.

Authors: Y G Yap; J Camm
Journal: BMJ Date: 2000-04-29

Review 3. New insights into the second generation antihistamines.

Authors: G M Walsh; L Annunziato; N Frossard; K Knol; S Levander; J M Nicolas; M Taglialatela; M D Tharp; J P Tillement; H Timmerman
Journal: Drugs Date: 2001 Impact factor: 9.546

Review 4. Drug induced QT prolongation and torsades de pointes.

Authors: Yee Guan Yap; A John Camm
Journal: Heart Date: 2003-11 Impact factor: 5.994

Review 5. Blockade of cardiac potassium and other channels by antihistamines.

Authors: E Delpón; C Valenzuela; J Tamargo
Journal: Drug Saf Date: 1999 Impact factor: 5.606

Review 6. Cardiac effects of ebastine and other antihistamines in humans.

Authors: A J Moss; J Morganroth
Journal: Drug Saf Date: 1999 Impact factor: 5.606

Review 7. Preclinical in vitro cardiac electrophysiology: a method of predicting arrhythmogenic potential of antihistamines in humans?

Authors: I Cavero; M Mestre; J M Guillon; E Heuillet; A G Roach
Journal: Drug Saf Date: 1999 Impact factor: 5.606

8. The role of the WHO programme on International Drug Monitoring in coordinating worldwide drug safety efforts.

Authors: S Olsson
Journal: Drug Saf Date: 1998-07 Impact factor: 5.606

Review 9. Ebastine: an update of its use in allergic disorders.

Authors: M Hurst; C M Spencer
Journal: Drugs Date: 2000-04 Impact factor: 9.546

10. Risk of ventricular arrhythmias associated with nonsedating antihistamine drugs.

Authors: F J de Abajo; L A Rodríguez
Journal: Br J Clin Pharmacol Date: 1999-03 Impact factor: 4.335